CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)	6 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Cash Flows From Operating Activities:
Net income (loss)	$ (1,661,432)	$ 995,118
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Share-based compensation	147,890	41,226
Depreciation and amortization	156,668	70,919
Deferred rent	1,624	886
Deferred tax asset	0	(747,000)
Bad debt expense	407,765	0
Changes in operating assets and liabilities:
Accounts receivable	794,580	(539,003)
Inventories	135,745	673,295
Prepaid expenses and other current assets	(366,035)	7,791
Other assets	(276,518)	0
Accounts payable and due to Forward China	(2,060,530)	(1,341,846)
Deferred income	(54,092)	(165,216)
Accrued expenses and other current liabilities	11,014	(233,162)
Net cash used in operating activities	(2,763,321)	(1,236,992)
Cash Flows From Investing Activities:
Purchases of property and equipment	(24,178)	(32,737)
Cash acquired in IPS purchase	0	600,435
Cash used to purchase IPS	0	(1,930,000)
Net cash used in investing activities	(24,178)	(1,362,302)
Cash Flows From Financing Activities:
Proceeds from Note issued to Forward China	0	1,600,000
Proceeds from Line of Credit borrowings	1,250,000	400,000
Repayment of Line of Credit borrowings	(300,000)	(550,000)
Repayment of notes payable	(120,803)	(143,011)
Repayments on capital equipment leases	(25,399)	(4,410)
Net cash provided by financing activities	803,798	1,302,579
Net decrease in cash	(1,983,701)	(1,296,715)
Cash at beginning of period	4,369,866	4,622,981
Cash at end of period	2,386,165	3,326,266
Supplemental Disclosure of Cash Flow Information:
Cash paid for interest	66,087	30,907
Cash paid for taxes	37,859	1,077
Supplemental Schedule of Non-Cash Investing and Financing Activities:
Shares issued to purchase IPS	$ 0	$ 500,000